TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 7 | 1 | 1 | 1 | 7 | 11 | 9 | 5 |
| S | %wins | 57 | 43 | 43 | 14 | 29 | 57 | 40 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/13/10 08:45 | 8/11/10 | HRS | Harris Corp /de/ | DE | Electr | ElcPrt | Search, Detection, Navigation | Katen Karen L | NY | D | S.d | -565 | 44.58 | 33 | -13 | -56 | 10 | D | -6 | 47 | -2 | -10 | 7 | -4 | -4 | -6 | 0 | -2 | 0 | 7 | 14 | -15 | |
5/13/09 14:47 | 5/12/09 | HRS | Harris Corp /de/ | DE | Electr | ElcPrt | Search, Detection, Navigation | Katen Karen L | NY | D | S.d | -129 | 29.37 | 33 | -4 | -31 | 10 | D | -36 | -45 | -14 | -27 | 7 | 7 | -1 | 8 | -1 | 6 | 3 | 1 | 57 | 76 | |
8/31/07 09:58 | 8/30/07 | HRS | Harris Corp /de/ | DE | Electr | ElcPrt | Search, Detection, Navigation | Katen Karen L | NY | D | S.d | -517 | 58.62 | 33 | -9 | -47 | 10 | D | 62 | 32 | 26 | 22 | 1 | 2 | 3 | 1 | 3 | 0 | 1 | 7 | -18 | -11 | |
5/2/06 17:02 | 5/1/06 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Katen Karen L | NY | O | Vice CB | S.d | -4,016 | 25.11 | 33 | -160 | -14 | 1,001 | B | 0 | 1 | -5 | 4 | 10 | 10 | ||||||||
8/17/05 08:33 | 8/15/05 | HRS | Harris Corp /de/ | DE | Electr | ElcPrt | Search, Detection, Navigation | Katen Karen L | NY | D | S | -330 | 37.43 | 33 | -9 | -47 | 10 | D | 141 | 66 | 13 | 27 | 19 | 14 | 4 | 2 | 0 | 1 | 8 | 21 | 27 | 25 | |
5/11/05 10:46 | 5/10/05 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Katen Karen L | NY | O | Vice CB | S | -1,865 | 27.78 | 33 | -67 | -8 | 810 | D | -12 | -21 | -1 | 9 | 5 | 3 | 2 | -1 | 1 | 3 | 0 | -3 | -18 | -6 |
11/19/03 13:40 | 11/18/03 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Katen Karen L | NY | O | EVP | S.d | -2,227 | 34.37 | 33 | -65 | -8 | 698 | D | -17 | 6 | 10 | 12 | 12 | 10 | 8 | 2 | 1 | -1 | 1 | 10 | 3 | -17 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |